BiotechTube

voclosporin + tacrolimus

Phase 3Withdrawn
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Renal Transplantation

Conditions

Renal Transplantation

Trial Timeline

Mar 1, 2013 → Dec 1, 2015

NCT ID
NCT01586845

About voclosporin + tacrolimus

voclosporin + tacrolimus is a phase 3 stage product being developed by Aurinia Pharmaceuticals for Renal Transplantation. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01586845. Target conditions include Renal Transplantation.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (3)

NCT IDPhaseStatus
NCT04701528Phase 2Completed
NCT01586845Phase 3Withdrawn
NCT00270634Phase 2Completed

Competing Products

20 competing products in Renal Transplantation

See all competitors
ProductCompanyStageHype Score
MBX 2109 + MBX 2109 + MBX 2109 + MBX 2109MBX BiosciencesPhase 1
28
LY3473329Eli LillyPhase 1
33
Tildacerfont/PlaceboSpruce BiosciencesPhase 2
44
SPR001Spruce BiosciencesPhase 2
44
SPR001Spruce BiosciencesPhase 2
44
Tildacerfont/PlaceboSpruce BiosciencesPhase 2
44
TildacerfontSpruce BiosciencesPhase 2
44
Drotrecogin alfa activated (Xigris)Eli LillyPhase 2
52
LY3819469Eli LillyPhase 1
33
Atezolizumab + CabozantinibChugai PharmaceuticalPhase 3
77
DS-6000a + DS-6000aDaiichi SankyoPhase 1
33
DS-1093aDaiichi SankyoPhase 1
33
CS-3150Daiichi SankyoPhase 3
77
AGS-16C3FAstellas PharmaPhase 1
33
AGS-16M8FAstellas PharmaPhase 1
33
CP-461Astellas PharmaPhase 2
52
roxadustatAstellas PharmaPhase 3
77
YM178Astellas PharmaPhase 1
33
intravenous immunoglobulins (IVIG)Astellas PharmaPhase 1
33
bixalomerAstellas PharmaPre-clinical
23

Other Products from Aurinia Pharmaceuticals

Voclosporin + Placebo Oral CapsulePhase 3
72
voclosporinPhase 3
72
voclosporin + PlaceboPhase 3
72
voclosporin + Ciclosporin + PlaceboPhase 3
72
Voclosporin + Placebo Oral CapsulePhase 3
72